BridgeMD
New treatment option for Lung Injury
Official title The Effects of Different Ventilation Modes on Patients With Pulmonary Lobe Resection
ClinicalTrials.gov ID: NCT06514729
What this study is testing
- What it's testing
- The objective of this study was to discuss the effects of different ventilation modes on patients with plasma inflammatory factor and respiratory function in patients with pulmonary removal.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75
You may be able to join if
- Comprehensive examination and analysis of imaging, laboratory examination and other comprehensive examinations, the diagnosis is clear, which is in...
- Age 18-75 years old, the gender is not limited;
- ASA grading Ⅰ \~ III level;
- It is expected that the single lung ventilation time is ≥1 hours, and ≤3 hours
You likely can't join if
- Emergency surgery;
- There is a taboos on the existence of systemic anesthesia;
- There is a history of acute chronic upper respiratory infections in the past January;
- Previous bronchial asthma, chronic obstructive pulmonary disease, bronchial dilatation, phthisis ,aspergillosis , acute respiratory distress syndrome...
- Merge the function of important organs such as heart, liver, and kidney;
- There was a history of chest surgery and the history of trauma;
See the full eligibility criteria
- Comprehensive examination and analysis of imaging, laboratory examination and other comprehensive examinations, the diagnosis is clear, which is in line with lobe resection surgical indications
- Age 18-75 years old, the gender is not limited;
- ASA grading Ⅰ \~ III level;
- It is expected that the single lung ventilation time is ≥1 hours, and ≤3 hours
- Emergency surgery;
- There is a taboos on the existence of systemic anesthesia;
- There is a history of acute chronic upper respiratory infections in the past January;
- Previous bronchial asthma, chronic obstructive pulmonary disease, bronchial dilatation, phthisis ,aspergillosis , acute respiratory distress syndrome or history of respiratory failure;
- Merge the function of important organs such as heart, liver, and kidney;
- There was a history of chest surgery and the history of trauma;
- Preoperative lung function test obvious abnormal abnormal abnormalities (1 second of exhalation (FEV1) \<60%);
- Patients refuse to participate in the clinical trial
The study team makes the final eligibility decision.
Where it's taking place
- Zunyi, Guizhou, China
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Zunyi, Guizhou, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.